drugset / Trial / NCT00301483
A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
RandomizedCrossoverSingle-blindTreatment
Summary
The main purpose of this study is to determine if HBOC-201 is safe and tolerable to trauma subjects, when given to treat the inadequate supply of blood and nutrients to tissues and organs.
Timeline
- Start
- 2004-07
- Primary completion
- 2008-09
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hemoglobin-based oxygen carrier-201 | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.